Analysis of risk factors for early-onset ventilator-associated pneumonia in a neurosurgical intensive care unit
- PMID: 35057762
- PMCID: PMC8772091
- DOI: 10.1186/s12879-022-07053-7
Analysis of risk factors for early-onset ventilator-associated pneumonia in a neurosurgical intensive care unit
Abstract
Background: Ventilator-associated pneumonia (VAP) is a severe infection among patients in the neurosurgery intensive care unit (NICU).
Methods: We retrospectively evaluated risk factors for early-onset ventilator-associated pneumonia (EOVAP) from January 2019 to December 2019 at a NICU. A total of 89 NICU patients who were intubated within 48 h of onset and whose mechanical ventilation time was at least 7 days were enrolled. We evaluated EOVAP that occurred within the first 7 days after the onset of mechanical ventilation. The enrolled patients had no history of chronic lung disease and no clinical manifestations of infection before intubation. Clinical data of patients were recorded, and the incidence of and risk factors for EOVAP were analyzed. Patients were also grouped by age (≥ 65 vs. < 65 years) and whether they had received hypothermia treatment or not.
Results: Among 89 mechanically ventilated patients (49 men and 40 women; the mean age ± SD was 60.1 ± 14.3 years), 40 patients (44.9%) developed EOVAP within 7 days and 14 patients (15.7%) had a multidrug resistant bacterial infection. Binary logistic regression analysis indicated that older age (≥ 65 years) (odds ratio [OR]:3.53, 95% confidence interval [CI]:1.27-9.79, P = 0.015) and therapeutic hypothermia (OR:3.68, CI:1.10-12.31, p = 0.034) were independent predictors of EOVAP. Levels of peripheral blood leukocytes, neutrophils and platelets were lower in the therapeutic hypothermia group than those who did not receive hypothermia treatment.
Conclusions: This study found that older age (≥ 65 years) and therapeutic hypothermia were independently associated with the risk of EOVAP in NICU patients.
Keywords: Aging; Early-onset ventilator-associated pneumonia; Hypothermia therapy; Neurosurgical intensive care unit; Risk factors.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome.Neurocrit Care. 2017 Oct;27(2):187-198. doi: 10.1007/s12028-017-0397-4. Neurocrit Care. 2017. PMID: 28432539
-
Microorganisms and clinical outcomes of early- and late-onset ventilator-associated pneumonia at Srinagarind Hospital, a tertiary center in Northeastern Thailand.BMC Pulm Med. 2021 Jan 30;21(1):47. doi: 10.1186/s12890-021-01415-8. BMC Pulm Med. 2021. PMID: 33516213 Free PMC article.
-
Retrospective analysis of the risk factors and pathogens associated with early-onset ventilator-associated pneumonia in surgical-ICU head-trauma patients.J Neurosurg Anesthesiol. 2010 Jan;22(1):32-7. doi: 10.1097/ANA.0b013e3181bdf52f. J Neurosurg Anesthesiol. 2010. PMID: 20027012
-
Subglottic secretion drainage for preventing ventilator-associated pneumonia: an updated meta-analysis of randomized controlled trials.J Trauma Acute Care Surg. 2012 May;72(5):1276-85. doi: 10.1097/TA.0b013e318247cd33. J Trauma Acute Care Surg. 2012. PMID: 22673255 Review.
-
What are the effects of care bundles on the incidence of ventilator-associated pneumonia in paediatric and neonatal intensive care units? A systematic review.J Spec Pediatr Nurs. 2019 Oct;24(4):e12264. doi: 10.1111/jspn.12264. Epub 2019 Jul 23. J Spec Pediatr Nurs. 2019. PMID: 31332968
Cited by
-
Performance Assessment of Medical Professionals in Prevention of Ventilator Associated Pneumonia in Intensive Care Units.Int J Gen Med. 2022 Apr 7;15:3829-3838. doi: 10.2147/IJGM.S363449. eCollection 2022. Int J Gen Med. 2022. PMID: 35418777 Free PMC article.
-
Evaluation of a clinical pharmacist-led antimicrobial stewardship program in a neurosurgical intensive care unit: a pre-and post-intervention cohort study.Front Pharmacol. 2023 Sep 22;14:1263618. doi: 10.3389/fphar.2023.1263618. eCollection 2023. Front Pharmacol. 2023. PMID: 37808195 Free PMC article.
-
The effect of an infection control guideline on the incidence of ventilator-associated pneumonia in patients admitted to the intensive care units.BMC Infect Dis. 2023 Mar 31;23(1):198. doi: 10.1186/s12879-023-08151-w. BMC Infect Dis. 2023. PMID: 37003964 Free PMC article. Clinical Trial.
-
Efficacy of Intermittent and Continuous Subglottic Secretion Drainage in Preventing the Risk of Ventilator-Associated Pneumonia: A Meta-Analysis of Randomized Control Trials.Medicina (Kaunas). 2023 Jan 31;59(2):283. doi: 10.3390/medicina59020283. Medicina (Kaunas). 2023. Retraction in: Medicina (Kaunas). 2023 Oct 26;59(11):1900. doi: 10.3390/medicina59111900. PMID: 36837483 Free PMC article. Retracted.
-
Lower respiratory tract infections due to multi‑drug resistant pathogens in central nervous system injuries (Review).Biomed Rep. 2023 Mar 6;18(4):30. doi: 10.3892/br.2023.1612. eCollection 2023 Apr. Biomed Rep. 2023. PMID: 37009311 Free PMC article. Review.
References
-
- Dahyot-Fizelier C, Frasca D, Lasocki S, Asehnoune K, Balayn D, Guerin AL, Perrigault PF, Geeraerts T, Seguin P, Rozec B, et al. Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open. 2018;8(10):e021488. doi: 10.1136/bmjopen-2018-021488. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources